deep brain stimulation device market forecast, deep brain stimulation device market trends, deep brain stimulation device market growth, deep brain stimulation device market share report, global deep brain stimulation device market, deep brain stimulation device market
What are the market size projections and growth rates for the Global Deep Brain Stimulation Device Market?
Recent years have seen the deep brain stimulation device market size blossom, climbing from $1.54 billion in 2024 to an expected $1.72 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. Factors such as increasing prevalence of neurological disorders, aging populations, limited efficacy of medications, boosted awareness and acceptance of these devices and improvements in surgical techniques have been accredited for the substantial growth experienced in the historic period.
In the forthcoming years, the deep brain stimulation device market is projected to expand at an even more accelerated pace, with the market set to rise to $2.67 billion by 2029 at a CAGR of 11.7%. Market growth during this forecast period is anticipated to root from a range of factors including expanding indications for deep brain stimulation (DBS), an uptick in healthcare expenditure, development of next-generation devices, increases in patient acceptance, government initiatives and funding and an escalation in industry collaborations and partnerships.
Discover more about these trends in the free sample of the Global Deep Brain Stimulation Device Market Report:
Why is the Deep Brain Stimulation Device Market growing?
The rise in prevalence of neurological diseases is acting as a key propellant for the growth of the deep brain stimulation device market. These medical conditions which affect the central and peripheral nervous systems are combatted using deep brain stimulation devices which control abnormal brain activity and adjust chemical imbalances in the brain that cause various conditions. Demonstrating this, in 2023, it was reported that around 50 million people globally had epilepsy, according to the World Health Organization (WHO). Furthermore, in 2022, the Parkinson’s Foundation reported a 50% increase in the new diagnosis rate of Parkinson’s disease, from the formerly expected 60,000 to 90,000 new diagnoses per year. As such, the rising prevalence of neurological disorders is significantly fueling the growth of the deep brain stimulation device market.
Which are the key segments in the Deep Brain Stimulation Device Market?
The global deep brain stimulation device market covered in this report is categorized by:
1) Product Type: Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator
2) Application: Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s Disease, Pain Management, Other Applications
3) End User: Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers
Secure your copy of the detailed market report to expedite your decision-making process:
https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-device-global-market-report
Who are the major players in the Deep Brain Stimulation Device Market?
Key players in the deep brain stimulation device market encompass Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation Ltd, NeuroPace, Inc., LivaNova PLC, Beijing PINS Medical Co. Ltd., SceneRay Corporation, Synapse Biomedical Inc., Deep Brain Innovation LLC, Nevro Corp., MicroPort NeuroTech, Stimwave LLC, Sapiens Neuro, Neuronetics Inc., BlueWind Medical Ltd., Brainsway Ltd., Neuralink Corporation, Med-Ally LLC, Axion BioSystems Inc., CereGate GmbH, NeuroSigma Inc., Bioinduction Ltd., Alpha Omega Engineering Ltd., Helius Medical Technologies, ANM Adaptive Neuromodulation GmbH, MagVenture A/S, Precisis AG, Monteris Medical Inc.
What are the current trends in the Deep Brain Stimulation Device Market?
Major companies in the deep brain stimulation device market are leveraging technological advancements such as connected care technology to enhance patient care by enabling remote programming, improving communication between patients and healthcare providers, and optimizing treatment outcomes for individuals with movement disorders. For instance, in January 2024, Abbott Laboratories received US Food and Drug Administration approval for the Liberta RC DBS system, the smallest rechargeable deep brain stimulation device for treating movement disorders. The Liberta RC DBS system features remote programming via the NeuroSphere Virtual Clinic and requires only 10 recharges per year. In addition, it’s size 31% smaller than competing devices and boasts a wireless charging system that can recharge the device every 37 days and offers customizable controls.
Which regions will see the fastest growth in the Deep Brain Stimulation Device Market?
North America was the largest region in the deep brain stimulation device market in 2024 while the Asia-Pacific region is predicted to be the fastest-growing over the forecast period as per the Global deep brain stimulation device market report. Other regions analyzed in this report include Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Deep Brain Stimulation Device Market Report 2025 Offer?
Deep brain stimulation devices are medical devices that deliver an electrical current directly to areas of the brain. The electrical impulses adjust for the chemical imbalances within the brain that cause various conditions and are used to treat neuropsychological disorders. The Deep Brain Stimulation Device Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Unlock exclusive market insights with your report purchase:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
Twitter: https://twitter.com/tbrc_info
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model